InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Creates Strategic Medical Billing Partnership, New Revenue Stream
Dec 15, 2022
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, announced a new strategic medical billing partnership with Nexus Dental Systems. According to the announcement, Vivos anticipates that the partnership will generate new revenue immediately and will enable the two companies, which currently operate independent billing platforms, to create one of the most comprehensive medical billing services in the dental industry. The new alliance will offer greater access to both in or out-of-network billing with all major medical insurance companies as well as facilitate enhanced case acceptances and insurance billing procedures and reimbursement. “For a long time, medical billing has been a barrier to wide acceptance of dental offices treating breathing and sleep disorders, which is why we have historically offered fee-based out-of-network claims assistance to Vivos providers and their patients,” said Vivos Therapeutics chair and CEO Kirk Huntsman in the press release. “Our Billing Intelligence Service currently achieves a 98% success rate for reimbursement on out-of-network oral appliance claims, which is extremely high. This new relationship will now give Vivos-trained dentists immediate access to some of the highest in-network reimbursement rates in the industry, allowing higher case acceptance for Vivos-trained providers. We believe this will create immediate additional revenue opportunities, not only for Vivos but for providers within each network, while patients pay less out-of-pocket expenses.”
To view the full press release, visit https://ibn.fm/2jaoh
About Vivos Therapeutics Inc.
Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution. It has proven effective in the treatment of an estimated 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.
NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork
More News
Nvidia’s Game of Thrones
Analysts and investors are asking whether the chipmaker needs to consider a successor to Jensen Huang, its C.E.O., as the company is engulfed in a spy scandal.
Why U.S. Business Deals Are Unlikely to Get Putin to Give Any Ground
President Vladimir V. Putin of Russia has shown a willingness to endure a high price to get what he wants in Ukraine, and he sees little reason to stop fighting now, analysts say.
Advent Calendars Go Beyond Chocolate, From Pickles to Protein Powder
Snacks, drinks and health foods are helping fuel a $2.6 billion industry that serves up a treat a day, from cheese to booze to dog biscuits.
Haaretz Expands US Presence Amid Israel’s Move to the Right
Haaretz has more than doubled the size of its American bureau, including hiring correspondents to cover beats like national politics and young American Jews.
Holiday hunger bill to face final Stormont hurdle
The new law would would help poorer families with food costs during school holidays.
Faisal Islam: What the boss of US tech giant Nvidia told me about China and national security
Huang, who is now being investigated over an affair with an alleged Chinese spy, is far more important to the future of the world order than other tech bosses.
China’s Trade Surplus Passes $1 Trillion at Record Pace
China’s factories are finding eager buyers worldwide, but the export boom is raising concerns about its impact on trading partner nations.
Trump says FBI investigating Nvidia boss's affair with alleged Chinese spy
The US president said he spoke with Jensen Huang on Monday and asked him about the affair with the alleged spy.
Justice Dept. Accuses Lyft of Disability Discrimination in Lawsuit
The department said Lyft and its drivers routinely deny rides to people who use stowable wheelchairs or travel with service animals. Lyft disputed the allegations.
Final chapter for bookshop after rise in bills
The Chicken and Frog in Brentwood says business rates and electricity bills have risen dramatically.
New chief outlines main issues facing Isle of Man
The chief minister says connectivity and food storage were among his top government priorities.
Australia considers criminal penalties for rogue AI in wake of OpenAI hack
AI safety regulator will also be created after a rogue OpenAI agent hacked government websites.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.